BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36017804)

  • 21. Hip Fractures in Patients With Liver Cirrhosis: Worsening Liver Function Is Associated with Increased Mortality.
    Hundersmarck D; Groot OQ; Schuijt HJ; Hietbrink F; Leenen LPH; Heng M
    Clin Orthop Relat Res; 2022 Jun; 480(6):1077-1088. PubMed ID: 34978539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community-acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores.
    Viasus D; Garcia-Vidal C; Castellote J; Adamuz J; Verdaguer R; Dorca J; Manresa F; Gudiol F; Carratalà J
    Medicine (Baltimore); 2011 Mar; 90(2):110-118. PubMed ID: 21358441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis.
    Chen PC; Chen BH; Huang CH; Jeng WJ; Hsieh YC; Teng W; Chen YC; Ho YP; Sheen IS; Lin CY
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1256-1263. PubMed ID: 31498284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Prediction of In-Hospital Mortality in Decompensated Cirrhosis with Acute-on-Chronic Liver Failure.
    Wong F; Reddy KR; Tandon P; Lai JC; Jagarlamudi N; Weir V; Kok B; Kalainy S; Srisengfa YT; Albhaisi S; Reuter B; Acharya C; Shaw J; Thacker LR; Bajaj JS
    Liver Transpl; 2022 Apr; 28(4):560-570. PubMed ID: 34564944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Area Deprivation Index and Gut-Brain Axis in Cirrhosis.
    Bajaj JS; Fagan A; McGeorge S; Sterling RK; Rogal S; Sikaroodi M; Gillevet PM
    Clin Transl Gastroenterol; 2022 Jun; 13(6):e00495. PubMed ID: 35537854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function.
    Bajaj JS; Cox IJ; Betrapally NS; Heuman DM; Schubert ML; Ratneswaran M; Hylemon PB; White MB; Daita K; Noble NA; Sikaroodi M; Williams R; Crossey MM; Taylor-Robinson SD; Gillevet PM
    Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G951-7. PubMed ID: 25258407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained impact of nosocomial-acquired spontaneous bacterial peritonitis in different stages of decompensated liver cirrhosis.
    Kimmann M; Tergast TL; Schultalbers M; Laser H; Gerbel S; Manns MP; Cornberg M; Maasoumy B
    PLoS One; 2019; 14(8):e0220666. PubMed ID: 31374111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MELD is the only predictor of short-term mortality in cirrhotic patients with C. difficile infection.
    Hong SJ; Feuerstadt P; Brandt LJ
    Dig Liver Dis; 2019 Feb; 51(2):275-280. PubMed ID: 30172651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrative analysis of the gut microbiota and faecal and serum short-chain fatty acids and tryptophan metabolites in patients with cirrhosis and hepatic encephalopathy.
    Wang Q; Chen C; Zuo S; Cao K; Li H
    J Transl Med; 2023 Jun; 21(1):395. PubMed ID: 37330571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stool microbiota show greater linkages with plasma metabolites compared to salivary microbiota in a multinational cirrhosis cohort.
    Cox IJ; Peña Rodríguez M; Fagan A; Rojas-Lara MV; Le Guennec A; Rodriguez-Alvarez F; McGeorge S; Escalona-Nandez I; Torre A; Bajaj JS
    Liver Int; 2022 Oct; 42(10):2274-2282. PubMed ID: 35635305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased Survival for Patients With Cirrhosis and Organ Failure in Liver Intensive Care and Validation of the Chronic Liver Failure-Sequential Organ Failure Scoring System.
    McPhail MJ; Shawcross DL; Abeles RD; Chang A; Patel V; Lee GH; Abdulla M; Sizer E; Willars C; Auzinger G; Bernal W; Wendon JA
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1353-1360.e8. PubMed ID: 25240417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in gut microbial function following liver transplant.
    Bajaj JS; Kakiyama G; Cox IJ; Nittono H; Takei H; White M; Fagan A; Gavis EA; Heuman DM; Gilles HC; Hylemon P; Taylor-Robinson SD; Legido-Quigley C; Kim M; Xu J; Williams R; Sikaroodi M; Pandak WM; Gillevet PM
    Liver Transpl; 2018 Jun; 24(6):752-761. PubMed ID: 29500907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures.
    Bajaj JS; O'Leary JG; Reddy KR; Wong F; Biggins SW; Patton H; Fallon MB; Garcia-Tsao G; Maliakkal B; Malik R; Subramanian RM; Thacker LR; Kamath PS;
    Hepatology; 2014 Jul; 60(1):250-6. PubMed ID: 24677131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the risk of decompensation by ascites and spontaneous bacterial peritonitis in cirrhosis.
    Dănulescu RM; Stanciu C; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):320-6. PubMed ID: 25076694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure.
    Hernaez R; Liu Y; Kramer JR; Rana A; El-Serag HB; Kanwal F
    J Hepatol; 2020 Dec; 73(6):1425-1433. PubMed ID: 32531416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MELD-Na Is More Strongly Associated with Risk of Infection and Outcomes Than Other Characteristics of Patients with Cirrhosis.
    Fricker ZP; Mukthinuthalapati VVPK; Akinyeye S; Chalasani N; Attar BM; Balakrishnan M; Ghabril M; Long MT
    Dig Dis Sci; 2021 Jan; 66(1):247-256. PubMed ID: 32100160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stage of cirrhosis predicts the risk of liver-related death in patients with low Model for End-Stage Liver Disease scores and cirrhosis awaiting liver transplantation.
    Wedd J; Bambha KM; Stotts M; Laskey H; Colmenero J; Gralla J; Biggins SW
    Liver Transpl; 2014 Oct; 20(10):1193-201. PubMed ID: 24916539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stool microbiota are superior to saliva in distinguishing cirrhosis and hepatic encephalopathy using machine learning.
    Saboo K; Petrakov NV; Shamsaddini A; Fagan A; Gavis EA; Sikaroodi M; McGeorge S; Gillevet PM; Iyer RK; Bajaj JS
    J Hepatol; 2022 Mar; 76(3):600-607. PubMed ID: 34793867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure.
    Sargenti K; Prytz H; Nilsson E; Kalaitzakis E
    Scand J Gastroenterol; 2015 Jul; 50(7):875-83. PubMed ID: 25697824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.